Onto Innovation INC

Market Movers (8-K)

NYSE
Onto Innovation Inc. announced the pricing of an upsized $1.5 billion offering of 0.00% Convertible Senior Notes due 2031 to qualified institutional buyers.
Capital raise
NYSE
Onto Innovation Inc. announced the results of its 2026 Annual Meeting, including the election of directors and approval of executive compensation.
NYSE
Onto Innovation Inc. announced plans for a $1.1 billion private offering of convertible senior notes due 2031 to qualified institutional buyers.
Capital raise
NYSE
Onto Innovation reported preliminary Q1 2026 revenue of $292 million, exceeding guidance, and raised its Q2 outlook.
Better than expected
NYSE
Onto Innovation Inc. announced record fourth quarter and full year 2025 revenue, driven by strategic acquisitions and a significant volume purchase agreement for its Dragonfly systems.
Worse than expected
NYSE
Onto Innovation Inc. has adopted a new nonqualified deferred compensation plan for eligible employees and non-employee directors, effective January 1, 2026.

Quarterly Earnings (10-Q)

NYSE
Onto Innovation Inc. reports a 9.5% revenue increase to $291.9 million in Q1 2026, but net income fell significantly to $33.8 million, alongside a strategic $710 million investment in Rigaku Holdings.
Worse than expected
Capital raise
NYSE
Onto Innovation Inc. reported a 14% revenue decline and a 47% net income drop in Q3 2025, while advancing its Semilab USA acquisition with a reduced valuation.
Worse than expected
Delay expected
NYSE
Onto Innovation Inc. reported a significant decline in Q2 net income and gross profit margin quarter-over-quarter, despite year-over-year revenue growth, while announcing a $545 million acquisition of Semilab USA.
Delay expected
Worse than expected
NYSE
Onto Innovation's Q1 2025 revenue increased by 16.5% year-over-year, driven by strong demand for metrology systems.
Better than expected
NYSE
Onto Innovation's Q3 2024 revenue increased by 21.7% year-over-year, driven by strong sales to NAND and DRAM customers.
Better than expected
NYSE
Onto Innovation's Q2 2024 revenue increased by 27.1% year-over-year, driven by strong sales in advanced nodes and specialty devices.
Better than expected

Annual Reports (10-K)

NYSE
Onto Innovation Inc. reported a 2% revenue increase to $1.005 billion for fiscal year 2025, driven by strategic acquisitions, but saw a 32.1% decline in net income due to higher operating costs and inventory write-downs.
Worse than expected
NYSE
Onto Innovation's 2024 revenue increased by 21% year-over-year, fueled by strong sales in its inspection business related to advanced packaging for AI chips.
NYSE
Onto Innovation Inc.'s 2023 10-K filing reveals a decrease in revenue compared to 2022, alongside strategic investments in research and development and a focus on managing supply chain challenges.
Worse than expected
Delay expected

Insider Trading (Form 4)

NYSE
Director May Su received a grant of 761 restricted stock units as part of her compensation, increasing her total beneficial ownership to 7,984 shares.
NYSE
Director Christopher A. Seams received 761 restricted stock units as part of a compensation grant, increasing his total holdings to 38,513 shares.
NYSE
Onto Innovation Inc. director Stephen S. Schwartz was granted 761 restricted stock units as part of standard equity compensation.
NYSE
Director David Brian Miller was granted 761 restricted stock units as part of standard equity compensation at Onto Innovation Inc.
NYSE
Director Susan D. Lynch was granted 761 restricted stock units as part of standard equity compensation.
NYSE
Director Stephen Douglas Kelley was granted 761 restricted stock units in Onto Innovation Inc. as part of standard equity compensation.

Proxy Statements (Def-14A)

NYSE
Onto Innovation reports $1 billion in 2025 revenue and outlines executive compensation and governance updates ahead of its May 2026 stockholder meeting.
NYSE
Onto Innovation Inc. will hold its annual meeting of stockholders on May 10, 2022, to vote on the election of directors, executive compensation, and the ratification of Ernst & Young LLP as the independent auditor.
NYSE
Onto Innovation announces its 2025 Annual Meeting of Stockholders to be held on May 21, 2025, covering director elections, executive compensation, and auditor ratification.
Better than expected
NYSE
Onto Innovation Inc. will hold its annual meeting of stockholders on May 10, 2022, to vote on the election of directors, executive compensation, and the ratification of Ernst & Young LLP as the independent registered public accounting firm.
NYSE
Onto Innovation Inc. has released its proxy statement outlining proposals for the upcoming annual meeting, including director elections, executive compensation approval, and auditor ratification.

Schedule 13G - Passive Investments

NYSE
Vanguard Portfolio Management has reported beneficial ownership of 5.53% of Onto Innovation Inc.'s common stock as of March 31, 2026.
NYSE
Vanguard Capital Management has reported beneficial ownership of over 5.23% of Onto Innovation Inc.'s common stock as of March 31, 2026.
NYSE
The Vanguard Group reports zero beneficial ownership in Onto Innovation Inc. following an internal realignment.
NYSE
BlackRock, Inc. has reported an increased beneficial ownership of 10.3% in ONTO INNOVATION INC., holding 5,039,082 shares of common stock.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, revealing a beneficial ownership of 11.3% in ONTO INNOVATION INC.'s common stock as of March 31, 2025.